Website Op-T is a clinical-stage company that has developed a new therapeutic for controlling inflammation in autoimmune diseases, acute inflammatory conditions, and certain chronic conditions across multiple species. The company has received IND approvals from the FDA for Phase 1 studies in humans with type 1 diabetes (T1D) and in healthy humans toward later studies…
Website Machavert is a pharmaceutical company that develops first-in-class targeted therapeutics to treat cancer. Machavert’a approach takes advantage of proprietary RAL GTPase inhibitors to control KRAS mutant cancer growth and metastasis to improve the lives of patients suffering from difficult-to-treat cancers. Machavert currently focuses on the development of novel RAL GTPase inhibitors for IND enabling…
Website Lohocla Research Corporation is dedicated to making a difference in improving people’s lives. A compassionate company committed to improving quality of life, Lohocla’s mission is to use genetic and genomic technology and biochemical and molecular-biology approaches in conjunction with rational computational drug design to develop diagnostic and therapeutic products for chronic pain, neurologic mental…
iC42 Clinical Research & Development supports pre-clinical and clinical drug development programs, assists with bringing drug candidates into clinical development, and serves as a resource for the biotech and pharmaceutical industry. Major focus areas include the evaluation of pharmacokinetics, drug metabolism, and the development of clinical management tools for pediatric patients. iC42 Clinical Research &…
Website Exxel Pharma is a development stage company that combines world-class leadership, expert technological know-how, and experience from the pharmaceutical industry to develop medicines for significant unmet medical needs. Exxel Pharma is focused on the development of innovative, small-molecule therapeutics for the treatment of chronic cough, pain, and CNS disorders, and aims to become the…